Extended Benefit with Bronchitol in Second Phase III Cystic Fibrosis Trial
16th
Dec 10
Release Date: 16/12/2010 12:00am
Pharmaxis today announced positive first results for the open label component of its second international Phase III trial of Bronchitol in people with cystic fibrosis.
Categories: News and Media